By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


EnGeneIC Pty Ltd 

105 Delhi Road, North Ryde

Sydney  New South Wales  2113  Australia
Phone: 612-9878-5456 Fax: 612-9878-5922



Start Up

Company News
EnGeneIC Pty Ltd Announces Publication In The Lancet Oncology Of First Clinical Study Employing EDV Nanocell Platform to Enable microRNA Replacement Therapy 9/5/2017 8:34:45 AM
EnGeneIC Pty Ltd Doses First Patient In U.S. Phase 1 Clinical Study Of Targeted EDV Nanocells In Recurrent Glioblastoma Multiforme 3/21/2017 6:31:25 AM
EnGeneIC Pty Ltd Receives FDA Orphan Drug Designation For Targeted EDV Nanocells To Treat Glioblastoma Multiforme 3/2/2017 6:38:43 AM
EnGeneIC Pty Ltd Enters Into Research Collaboration With Takeda (TKPYY) To Develop EDV-Based Immunomodulatory Therapies For Oncology 10/10/2016 7:30:36 AM
EnGeneIC Pty Ltd's Joint-CEO And Co-Founder, Jennifer Macdiarmid, Ph.D., Recognized In Innovation Category In The Australian Financial Review And Westpac 100 Women Of Influence Awards For 2016 10/4/2016 8:44:38 AM
EnGeneIC Pty Ltd Named One Of Science Meets Business Top 25 Australian Research And Development Spin-Off Companies 3/10/2016 9:17:39 AM
EnGeneIC Pty Ltd To Present At BIO CEO & Investor Conference 2016 2/3/2016 9:35:54 AM
EnGeneIC Pty Ltd Strengthens Board Of Directors To Support U.S. Expansion 1/25/2016 6:36:52 AM
EnGeneIC Pty Ltd To Present At The Stifel 2015 Healthcare Conference 11/11/2015 12:57:04 PM
EnGeneIC Pty Ltd To Initiate U.S. Phase 1 Clinical Study Using Targeted EDV Nanocells To Treat Advanced Glioma Patients 9/16/2015 7:32:07 AM